Skip to main content

Advertisement

Table 1 Tumor characteristics named as relevant for treatment decision

From: Radiotherapy for pelvic nodal recurrences after radical prostatectomy: patient selection in clinical practice

Characteristic % (number of centers)
PSA doubling time 57% (n = 8)
Initial high-risk disease 36% (n = 5)
PSA level at recurrence 29% (n = 4)
Size of lymph node recurrence 14% (n = 2)
Interval since RP 14% (n = 2)
  1. Multiple factors were named by some centers. PSA, prostate-specific antigen. RP, radical prostatectomy.